MCU and COVID-19: In our current study, we found that MCU expression was significantly downregulated in both AT2 and AT1 cells in patients with COVID-19, suggesting that the destruction/blocking of MCU channels in alveolar epithelial cells by SARS-CoV-2 infection may be a potential mechanism underlying the blocking of AT2 to AT1 conversion.